Trial
NCT03370510
Translating Neuroprediction Into Precision Medicine Via Brain Priming
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Autism Spectrum Disorder
Intervention
Oxytocin
Why stopped
Covid-19 Pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-09